4.6 Article

Spinal Cord Diffuse Midline Gliomas With H3 K27m-Mutant: Clinicopathological Features and Prognosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Neurosciences

The molecular characteristics of spinal cord gliomas with or without H3 K27M mutation

Rui-Chao Chai et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2020)

Article Multidisciplinary Sciences

The integrated genomic and epigenomic landscape of brainstem glioma

Lee H. Chen et al.

NATURE COMMUNICATIONS (2020)

Article Pathology

H3 K27M-mutant diffuse midline gliomas in different anatomical locations

Leiming Wang et al.

HUMAN PATHOLOGY (2018)

Editorial Material Clinical Neurology

BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas

Xin Chen et al.

JOURNAL OF CLINICAL NEUROSCIENCE (2017)

Article Oncology

Characteristics of H3 K27M-mutant gliomas in adults

David Meyronet et al.

NEURO-ONCOLOGY (2017)

Letter Neurosciences

Diffuse non-midline glioma with H3F3A K27M mutation: a prognostic and treatment dilemma

Giselle Lopez et al.

ACTA NEUROPATHOLOGICA COMMUNICATIONS (2017)

Article Clinical Neurology

Imaging Characteristics of Pediatric Diffuse Midline Gliomas with Histone H3 K27M Mutation

M. S. Aboian et al.

AMERICAN JOURNAL OF NEURORADIOLOGY (2017)

Editorial Material Clinical Neurology

High frequency of H3F3A K27M mutations characterizes pediatric and adult high-grade gliomas of the spinal cord

Marco Gessi et al.

ACTA NEUROPATHOLOGICA (2015)

Article Oncology

Molecular analysis of diffuse intrinsic brainstem gliomas in adults

German Reyes-Botero et al.

JOURNAL OF NEURO-ONCOLOGY (2014)

Article Oncology

H3F3A K27M mutations in thalamic gliomas from young adult patients

Koki Aihara et al.

NEURO-ONCOLOGY (2014)

Letter Clinical Neurology

Low rate of R132H IDH1 mutation in infratentorial and spinal cord grade II and III diffuse gliomas

Benjamin Ellezam et al.

ACTA NEUROPATHOLOGICA (2012)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)